Concepedia

MD Rawlins

MR

6

Publications

362

Citations

6

H-Index

1985

Active since

Affiliations

Newcastle University(Current)

MD Rawlins is an author at Newcastle University specializing in clinical safety, patient safety, and drug safety.

Top concepts

Publications per year

1985–1995

6

Publications

6

Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom [see comments]

KJ Belton, Sarah Payne, MD Rawlins et al. · British Journal of Clinical Pharmacology · 1995 · 187 citations · Full text

, , +26

Determinants of plasma alpha 1‐acid glycoprotein (AAG) concentrations in health.

PG Blain, JC Mucklow, MD Rawlins et al. · British Journal of Clinical Pharmacology · 1985 · 79 citations · Full text

Guidelines for company‐sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993) [see comments]

P.J. Waller, SM Wood, AM Breckenridge et al. · British Journal of Clinical Pharmacology · 1994 · 30 citations · Full text

, , +11

Review of yellow cards (1986): report to the Committee on the Safety of Medicines.

JL Bem, AM Breckenridge, RD Mann et al. · British Journal of Clinical Pharmacology · 1988 · 23 citations · Full text

United Kingdom Product Licence applications involving new active substances, 1987‐1989: their fate after appeals.

MD Rawlins, D.B. Jefferys · British Journal of Clinical Pharmacology · 1993 · 22 citations · Full text

, , +23

Rows per page

1–5 of 6